Related references
Note: Only part of the references are listed.Parkinson disease
R. Balestrino et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention
Yujeong Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Benjamin G. Trist et al.
AGING CELL (2019)
Association between Hypertension and the Risk of Parkinson's Disease: A Meta-Analysis of Analytical Studies
Jiahao Chen et al.
NEUROEPIDEMIOLOGY (2019)
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease
Santiago Perez-Lloret et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
New and old roles of the peripheral and brain renin-angiotensin-aldosterone system (RAAS): Focus on cardiovascular and neurological diseases
A. Mascolo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Oxidative stress and cellular pathologies in Parkinson's disease
Lesly Puspita et al.
MOLECULAR BRAIN (2017)
The epidemiology of Parkinson's disease: risk factors and prevention
Alberto Ascherio et al.
LANCET NEUROLOGY (2016)
Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons
Consiglia Pacelli et al.
CURRENT BIOLOGY (2015)
Cerebral small vessel disease and incident parkinsonism The RUN DMC study
Helena M. van der Holst et al.
NEUROLOGY (2015)
Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
Yen-Chieh Lee et al.
PLOS ONE (2014)
Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update
Lars Brichta et al.
FRONTIERS IN NEUROANATOMY (2014)
Dopamine-Angiotensin Interactions in the Basal Ganglia and Their Relevance for Parkinson's Disease
Jose L. Labandeira-Garcia et al.
MOVEMENT DISORDERS (2013)
A Role for the Brain RAS in Alzheimer’s and Parkinson’s Diseases
John W. Wright et al.
Frontiers in Endocrinology (2013)
Neuroinflammation in Parkinson's disease
Etienne C. Hirsch et al.
PARKINSONISM & RELATED DISORDERS (2011)
A new look at the renin-angiotensin system-Focusing on the vascular system
Aurelie Nguyen Dinh Cat et al.
PEPTIDES (2011)
The role of the central renin-angiotensin system in Parkinson's disease
Birgit Mertens et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2010)
The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease
Belen Joglar et al.
JOURNAL OF NEUROCHEMISTRY (2009)
USE OF ANTIHYPERTENSIVES AND THE RISK OF PARKINSON DISEASE
Alberto Ascherio et al.
NEUROLOGY (2009)
Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS
J. Rodriguez-Pallares et al.
NEUROBIOLOGY OF DISEASE (2008)
Use of antihypertensives and the risk of Parkinson disease
Claudia Becker et al.
NEUROLOGY (2008)
Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons
P. Rey et al.
NEUROBIOLOGY OF AGING (2007)
The AT2 receptor - A matter of love and hate
UM Steckelings et al.
PEPTIDES (2005)
Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression
T Chabrashvili et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Share Paper
